ITEOS THERAPEUTICS INC (ITOS)

US46565G1040 - Common Stock

7.66  -0.14 (-1.79%)

Premarket: 7.76 +0.1 (+1.31%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
35.00M12.60M267.60M344.80M0.00
Operating Expenses
185.34M163.70M141.30M99.90M45.20M
Research and Development
135.70M113.30M97.40M59.40M29.90M
Selling, General, and Administrative Expenses
49.64M50.40M43.90M40.50M15.30M
Operating Income
-150.34M-151.10M126.30M244.90M-45.20M
Interest Income/Expense
31.05M31.77M11.40MN/AN/A
Other Income/Expense
7.12M10.30M11.10M11.60M7.20M
Income Before Taxes
-112.17M-109.03M148.70M256.50M-38.10M
Income Tax
9.08M3.61M52.10M41.90M-100.00K
Net Income
-121.25M-112.64M96.70M214.50M-43.40M
EBITDA
-149.23M-150.20M127.10M245.50M-44.70M
 
Per Share Data
EPS Diluted Total Ops
-3.15-3.152.565.68-1.24
Non GAAP EPS
-3.15-3.15N/A5.61N/A
 
Statistics
Profit Margin
-346.44%-894.34%36.14%62.21%N/A
Operating Profit Margin
-429.55%-1199.69%47.20%71.03%N/A

All data in USD

Charts